Pure Financial Statements From 2010 to 2024
PRXTFDelisted Stock | USD 0.01 0.00 0.00% |
Check Pure Extracts financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pure Extracts' main balance sheet or income statement drivers, such as , as well as many indicators such as . Pure financial statements analysis is a perfect complement when working with Pure Extracts Valuation or Volatility modules.
Pure |
Pure Extracts Technologies Company Return On Equity Analysis
Pure Extracts' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pure Extracts Return On Equity | -1.39 |
Most of Pure Extracts' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pure Extracts Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Pure Extracts Technologies has a Return On Equity of -1.3885. This is 94.21% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.
Pure Extracts Techno Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pure Extracts's current stock value. Our valuation model uses many indicators to compare Pure Extracts value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pure Extracts competition to find correlations between indicators driving Pure Extracts's intrinsic value. More Info.Pure Extracts Technologies is regarded fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pure Extracts' earnings, one of the primary drivers of an investment's value.About Pure Extracts Financial Statements
Pure Extracts stakeholders use historical fundamental indicators, such as Pure Extracts' revenue or net income, to determine how well the company is positioned to perform in the future. Although Pure Extracts investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pure Extracts' assets and liabilities are reflected in the revenues and expenses on Pure Extracts' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pure Extracts Technologies. Please read more on our technical analysis and fundamental analysis pages.
Pure Extracts Technologies Corp. engages in the extraction and processing of cannabis, hemp, and functional mushrooms to produce oils and various derivative products in Canada. Pure Extracts Technologies Corp. is headquartered in Pemberton, Canada. Pure Extracts is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Pure Pink Sheet
If you are still planning to invest in Pure Extracts Techno check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pure Extracts' history and understand the potential risks before investing.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |